You Can Prevent Alzheimer’s: The New Science of Brain Health

The ABCDE framework, published in Nature Mental Health (January 2024), guides a holistic assessment and intervention strategy. 'A' (Anthropometrics) focuses on body composition, including belly fat, muscle mass, and bone density, as these are critical brain markers. 'B' (Blood-based biomarkers) involves a deep dive into cholesterol, inflammatory, nutritional, metabolic (e.g., blood sugar, insulin, HbA1c), and hormonal markers. 'C' (Cognitive testing) involves regular assessments, often through digital activities. 'D' (DNA) emphasizes genetic testing, particularly for ApoE4, to personalize care. 'E' (Emotional and Social support) highlights the importance of stress management, social engagement, meaningful life, and learning new things. This integrated approach recognizes that 'body disease' often manifests as 'brain disease' and that factors below the neck significantly impact neurological health.

While any physical activity is better than none, Dr. Isaacson emphasizes intentional exercise for brain health. For fat loss, Zone 2 cardio (where you can talk but are slightly short of breath) is recommended, ideally for 40-60 minutes, three times a week. This can be achieved through fast walking, weighted vests, or uphill walking. Strength training twice a week is crucial for building muscle mass, which is metabolically active and helps manage blood sugar. He notes that crunches won't fix belly fat, which is primarily driven by sugar and starch intake. The goal is to optimize body composition, not just weight.

Dr. Isaacson advocates for a 'precision nutrition' approach, acknowledging that different people thrive on different dietary patterns. He highlights the benefits of a Mediterranean-style diet, rich in omega-3 fatty acids (especially DHA for ApoE4 carriers), monounsaturated fats from quality olive oil (which should be bitter and burn the tongue due to polyphenols), avocados, and fatty fish. Berries and leafy green vegetables are emphasized for their antioxidant properties, with studies showing berries can delay cognitive decline. He promotes a 'plant-rich' diet over strictly 'plant-based' (vegan) and stresses the importance of quality protein sources. The 'ELF diet' (Eat Less Food) is also mentioned, referencing the Okinawa principle of 'Hari Hachi Bu' (eating until 80% full) and studies linking lower calorie intake to delayed cognitive decline. However, he cautions against calorie restriction for those trying to build muscle and emphasizes distinguishing between good and bad carbohydrates.

Dr. Isaacson stresses that even with perfect diet and exercise, brain health will suffer without adequate sleep. He cites cases where improving sleep alone led to reductions in amyloid and improved cognition. Sleep quality, particularly deep sleep (for waste clearance) and REM sleep (for memory consolidation), is crucial. The 'cheat code' for more quality sleep is simply sleeping longer. Practical tips include sleeping in a dark, cool room, using earplugs and eye shades, and avoiding caffeine after 11 AM/PM (due to its 5-6 hour half-life). He also emphasizes 'putting electronics to bed' by 9:30-10:00 PM to reduce light exposure and rumination, which can fast-forward cognitive decline.

Dr. Hyman and Dr. Isaacson argue that Alzheimer's and other neurodegenerative diseases begin silently decades before symptoms appear, often in people's 30s, 40s, and 50s. The current 'sick care' system only intervenes once symptoms like memory loss manifest, which is often too late. They advocate for a 'precision neurology' approach, recognizing that each patient's disease has different causes and requires individualized treatment. This contrasts with the failed amyloid hypothesis, which assumed amyloid plaques were the primary cause, despite evidence that many people with amyloid in their brains never develop dementia, and that amyloid is often a 'band-aid' response to inflammation.

Dr. Isaacson's team is developing what they envision as 'the cholesterol test for the brain,' a panel of 5-10 markers that can be tracked over time, starting in people's 20s and 30s. Current available tests like p-tau 217 and amyloid biomarkers (AD4240) are useful for symptomatic individuals, but the goal is to establish normal reference ranges for younger, asymptomatic populations. The challenge lies in understanding how factors like time of day for blood draws or transient viral infections might influence these markers, necessitating more nuanced interpretation. The ultimate aim is to make these tests accurate, accessible, and affordable, guiding personalized interventions.

Dr. Isaacson shares compelling evidence from his research, including the case of 'Simon,' an ApoE4/4 individual (high genetic risk) whose brain volume grew twice over a year, and whose amyloid and tau biomarkers normalized. This was documented through MRI scans and blood tests. He emphasizes that while he remains conservative in his claims due to the radical nature of these findings, the objective data is consistent across multiple patients. This aligns with the work of other researchers like Dale Bredesen, who have also shown increases in hippocampus size and overall brain volume.

Dr. Isaacson argues that the rapid drop in estrogen during perimenopause, especially in genetically susceptible women (e.g., ApoE4 carriers), significantly impacts brain health. His research, including a women's brain imaging study at Cornell, showed that women on hormone replacement therapy had better brain volumes and less amyloid. He criticizes the 'misogynistic research infrastructure' for neglecting this area, leading to a lack of studies on bioidentical hormones. His team's N-of-1 studies have shown 'amazing success' with bioidentical hormone replacement therapy (HRT) in reducing tau protein levels and improving other brain biomarkers, even when symptoms are mild. They are also conducting novel research by taking multiple blood draws throughout the menstrual cycle to understand how fluctuating hormones affect brain biomarkers like p-tau 217, aiming to establish corrected reference ranges.